CIK: 0001420995 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value ($000): $68,221 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BRK/A | BERKSHIRE HATHAWAY INC DEL | 76 | $39,354 | 57.7% | $330761.80 | +50.5% | CL A | 084670108 |
| ABNB | AIRBNB INC | 82,947 | $10,630 | 15.6% | $115.47 | +1.3% | COM CL A | 009066101 |
| IRON | DISC MEDICINE INC | 110,488 | $4,906 | 7.2% | $49.79 | -28.7% | COM | 254604101 |
| CFLT | CONFLUENT INC | 130,383 | $4,604 | 6.7% | $23.18 | +20.7% | CLASS A COM | 20717M103 |
| — | VIGIL NEUROSCIENCE INC | 192,973 | $1,814 | 2.7% | $0.01 | — | COM | 92673K108 |
| TNYA | TENAYA THERAPEUTICS INC | 291,828 | $1,713 | 2.5% | $21.49 | -73.0% | COM | 87990A106 |
| — | RAPT THERAPEUTICS INC | 73,383 | $1,372 | 2.0% | $20.30 | — | COM | 75382E109 |
| BZ | KANZHUN LIMITED | 82,083 | $1,235 | 1.8% | $15.05 | — | SPONSORED ADS | 48553T106 |
| XLO | XILIO THERAPEUTICS INC | 249,635 | $654 | 1.0% | $2.41 | +26.1% | COM | 98422T100 |
| PGNY | PROGYNY INC | 11,943 | $470 | 0.7% | $36.09 | 0.0% | COM | 74340E103 |
| — | SURROZEN INC | 718,950 | $395 | 0.6% | $7.08 | — | COM | 86889P109 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 1,100 | $375 | 0.5% | $220.20 | +48.2% | CL B NEW | 084670702 |
| — | VOR BIOPHARMA INC | 91,910 | $284 | 0.4% | $43.10 | — | COM | 929033108 |
| AMPL | AMPLITUDE INC | 18,944 | $208 | 0.3% | $33.83 | -68.1% | COM CL A | 03213A104 |
| COUR | COURSERA INC | 15,710 | $205 | 0.3% | $12.94 | -7.5% | COM | 22266M104 |
| SRZNW | SURROZEN INC | 33,333 | $2 | 0.0% | $1.14 | — | *W EXP 08/01/2 | 86889P117 |